All In MedTech

Device type · NHX

Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about NHX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

NHX

Immunology

Device class

Class II

FDA decisions since 2015

2

510(k), De Novo and PMA

Adverse event reports

1

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
Product code
NHX
Device class
Class II
Review panel
Immunology
Regulation
21 CFR 866.5775

Latest FDA decisions

All decisions for NHX

Reports received

1

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

1

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 241000
Feb 240000
Mar 240000
Apr 240000
May 240000
Jun 240000
Jul 241000
Aug 241000
Sep 240000
Oct 241000
Nov 240000
Dec 240000
Jan 250000
Feb 250000
Mar 250000
Apr 250000
May 250000
Jun 250000
Jul 250000
Aug 250000
Sep 251000
Oct 251000
Nov 250000
Dec 251000
Jan 260000
Feb 260000
Mar 260000
Apr 260000
May 260000
Jun 260000
Jul 260000
Aug 260000
Sep 260000
Oct 260000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Incorrect, Inadequate or Imprecise Result or Readings1
  • Non Reproducible Results1

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions1

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Mckesson Medical-Surgical Inc. Corporate Office

    Z-1853-2025 · Started Apr 24, 2025 · Posted by FDA May 27, 2025

    Reason given: transit delays of certain cold chain products due to severe thunderstorms which may caused the products to be stored outside the recommended labeled storage conditions. This failure could increase the probability of an incorrect test result or a delayed test result.

    Cause as FDA categorized it: Storage

  • Bio-Rad Laboratories, Inc.

    Z-1377-2023 · Started Feb 21, 2023 · Posted by FDA Apr 12, 2023

    Reason given: Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI...

    Cause as FDA categorized it: Under Investigation by firm

  • Bio-Rad Laboratories, Inc.

    Z-1378-2023 · Started Feb 21, 2023 · Posted by FDA Apr 12, 2023

    Reason given: Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI...

    Cause as FDA categorized it: Under Investigation by firm

6 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.